Cancer Waiting Times - NHS England
wo week wait for symptomatic breast patients (cancer not initially suspected)oThose patients urgently referred with breast symptoms (where cancer was notinitially suspected) should experience a maximum waiting time of two weeks tosee a specialist. This maximum waiting time requirement was introduced inquarter four 2009/10, when 92% of patients were seen within 2 weeks ofreferral. The operational standard for this measure is 93%In total, 46,264 patients with exhibited breast symptoms, where cancer was notinitially suspected, were seen in quarter three 2019/20 after being urgentlyreferred. Of these, 87.3% were seen within 14 days, compared to 85.4% in Q22019/20, and 88.7% in Q3 2018/19.The proportion of patients seen within 14 days varies amongst providers from0.0% to 100.0%. 47 providers missed the operational standard of 93% ofpatients being seen within 14 days.A graph of the trend in reported performance over time is shown below:Figure 2: Proportion of patients seen within 14 days of referral for breast symptoms, where cancer is notinitially suspected4
One Month (31-day) diagnosis to first treatment waitPatients should experience a maximum wait of one month (31 days) betweenreceiving their diagnosis and the start of first definitive treatment, for allcancers. This is measured from the point at which the patient is informed of adiagnosis of cancer and agrees their package of care. The operationalstandard for this measure is 96%.In quarter three 2019/20, 77,309 patients began a first definitive treatment forcancer. 96.0% of these patients started that treatment within 31 days,compared to 96.1% for Q2 2019/20 and 96.8% from Q3 2018/19.This proportion of patients that began first definitive treatment within 31 dayswas lower for admitted patients (94.7%) than for non-admitted patients(98.5%).The proportion of patients treated within 31 days of diagnosis at providerswhich treated at least 5 patients varies from 73.9% to 100.0% by provider – allbut 39 providers treated at least 96% of patients within 31 days of diagnosis.A graph showing the trends over time is shown below:Figure 3: Proportion of patients waiting 31 days or less for first treatment following diagnosis5
One Month (31-day) diagnosis to first treatment wait by cancer typeIn quarter three 2019/20, 77,309 patients began a first definitive treatment forcancer. The proportion of patients treated within 31 days of diagnosis forvarious cancer types is as follows:oooooBreast cancers – 97.6%Lung cancers – 97.4%Lower gastrointestinal cancers – 96.2%Urological cancers – 93.7%Skin cancers – 94.9%6
31-day wait for second or subsequent treatmentAnti-cancer drug treatmentsPatients should experience a maximum wait of 31 days for a second orsubsequent treatment. Where that treatment is an anti-cancer drug regimen,the operational standard is 98%.In quarter three 2019/20, 99.3% of patients receiving an anti-cancer drugregimen waited 31 days or less for that second or subsequent treatment,compared to 99.2% in Q2 2019/20 and 99.4% in Q3 2018/19.The proportion of patients in quarter three 2019/20, waiting 31 days or less fora subsequent anti-cancer drug treatment was lower for admitted patients(99.1%) than non-admitted patients (99.6%)The proportion of patients waiting for 31 days or less varies from 92.2% to100.0% by provider. 10 providers did not meet the target of treating at least98% within 31 days.A graph showing the trends over time is shown below:Figure 4: Proportion of patients on an anti-cancer drug regimen waiting 31 days or less for second orsubsequent treatment7
SurgeryPatients should experience a maximum wait of 31 days for a second orsubsequent surgical treatment. The operational standard for this measure is94%.In quarter three 2019/20, 91.4% of patients waited 31 days or less for theirsecond or subsequent treatment, compared to 91.4% in Q2 2019/20 and93.1% of patients in Q3 2018/19.The proportion of patients in quarter three 2019/20 waiting 31 days or less waslower for ad
Review of Cancer Waiting Times Standards (January 2011) recommended that the current waiting time requirements for cancer should be retained. It was identified that shorter waiting times can help to ease patient anxiety and, at best, may lead to earlier diagnosis, quicker treatment, a lower risk of complications, an enhanced patient
Returning NHS waiting times to 18 weeks for routine treatment 4 . Introduction At the end of April 2020, the NHS in England was asked to begin a cautious programme to resume the routine services suspended in response to COVID-19
It is now referenced in the Mandate to NHS England, the NHS Planning Guidance and the CCG Improvement and Assessment Framework. The RightCare programme includes the Commissioning for Value packs and tools, the NHS Atlas series and a number of casebooks. NHS England has committed significant funding to rolling out the RightCare
Amy Bowen, NHS RightCare Pathways Lead, NHS RightCare NHS Diabetes Programme Director's Group Jillian Scott, Health Facilitator- Northern Trust, Northern Ireland Professor Gyles Glover, Co-Director, Learning Disabilities Observatory Team, Public Health England Sue Turner, Learning Disability Lead, National Development Team for Inclusion (NDTI)
Ovarian cancer is the seventh most common cancer among women. There are three types of ovarian cancer: epithelial ovarian cancer, germ cell cancer, and stromal cell cancer. Equally rare, stromal cell cancer starts in the cells that produce female hormones and hold the ovarian tissues together. Familial breast-ovarian cancer
Introduction. Health Education England has kindly supported Education and Employers since the launch of . our dedicated campaign, NHS Ambassadors in 2018; however, NHS staff have been involved with our work and volunteering on our programmes from the outset, when the charity first launched in 2009. Over the years, Health Education England have .
bunchberry dr nhs wms amb . burgundy ln nhs wms twl . burkwood dr nhs wms amb . burning tree st chs wms twl . burnock dr chs wms mbe . burr ridge rd nhs nms twl . burrwood ave nhs nms ang . burrwood st nhs nms ang . burt dr chs cms lce
of NHS Direct, and led the team preparing New Labour's first White Paper, The New NHS: Modern, dependable, which laid the foundations and structure for the current NHS reform programme. He was a member of the top management board of the NHS for 12 years, between 1988 and 2000. His earlier career included 23 years in NHS management,
American Revolution in Europe working to negotiate assistance from France, Spain, and the Netherlands. Foreign Assistance French ultimately provided critical military and financial assistance Spain and the Netherlands provided primarily financial assistance to the American cause. A comparison of the resources held by the British and by the colonies: The population of the thirteen colonies .
